Use of vancomycin as a surrogate for dalbavancin in vitro susceptibility testing: results from the DISCOVER studies

被引:0
作者
Michael W Dunne
Dan Sahm
Sailaja Puttagunta
机构
[1] Durata Therapeutics,
[2] Inc.,undefined
[3] Branford,undefined
[4] CT,undefined
[5] International Health Care Associates,undefined
[6] Inc,undefined
来源
Annals of Clinical Microbiology and Antimicrobials | / 14卷
关键词
Susceptibility testing; Vancomycin; Dalbavancin; Antimicrobial agents; Acute bacterial skin and skin structure infections;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 20 条
  • [1] Use of vancomycin as a surrogate for dalbavancin in vitro susceptibility testing: results from the DISCOVER studies
    Dunne, Michael W.
    Sahm, Dan
    Puttagunta, Sailaja
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2015, 14
  • [2] A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
    Koeth, Laura M.
    DiFranco-Fisher, Jeanna M.
    McCurdy, Sandra
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2015, (103):
  • [3] Vancomycin-resistant Enterococcus spp.: validation of susceptibility testing and in vitro activity of vancomycin, linezolid, tigecycline and daptomycin
    Rathe, Mathias
    Kristensen, Lise
    Ellermann-Eriksen, Svend
    Thomsen, Marianne Kragh
    Schumacher, Helga
    APMIS, 2010, 118 (01) : 66 - 73
  • [4] Results of an interlaboratory test on antimicrobial susceptibility testing of bacteria from animals by broth microdilution
    Wallmann, Juergen
    Boettner, Alexander
    Goossens, Luc
    Hafez, H. Mohamed
    Hartmann, Katrin
    Kaspar, Heike
    Kehrenberg, Corinna
    Kietzmann, Manfred
    Klarmann, Dieter
    Klein, Guenter
    Krabisch, Peter
    Kuehn, Tilman
    Luhofer, Gabriele
    Richter, Angelika
    Schulz, Bianka
    Schwarz, Stefan
    Sigge, Claudia
    Traeder, Wolfgang
    Waldmann, Karl-Heinz
    Werckenthin, Christiane
    Zschiesche, Eva
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 27 (06) : 482 - 490
  • [5] Use of spectrophotometric reading for in vitro antifungal susceptibility testing of Aspergillus spp.
    Dannaoui, E
    Persat, F
    Monier, MF
    Borel, E
    Piens, MA
    Picot, S
    CANADIAN JOURNAL OF MICROBIOLOGY, 1999, 45 (10) : 871 - 874
  • [6] In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study
    Karlowsky, James A.
    Adam, Heather J.
    Poutanen, Susan M.
    Hoban, Daryl J.
    Zhanel, George G.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 69 (03) : 342 - 347
  • [7] In vitro susceptibility to methicillin, vancomycin and linezolid of staphylococci isolated from bloodstream infections in eastern Turkey
    Tekin, Alicem
    Dal, Tuba
    Deveci, Ozcan
    Tekin, Recep
    Ozcan, Nida
    Atmaca, Selahattin
    Dayan, Saim
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2014, 45 (03) : 829 - 833
  • [8] Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007)
    Biedenbach, Douglas J.
    Jones, Ronald N.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2009, 64 (02) : 177 - 184
  • [9] Comparison of three antifungal susceptibility testing methods for the in vitro testing of Candida isolates from patients with HIV infection
    Ruhnke, M
    SchmidtWesthausen, A
    Trautmann, M
    MYCOSES, 1996, 39 : 47 - 50
  • [10] In vitro activity of ceftobiprole and dalbavancin against a collection of coagulase-negative staphylococci isolates from clinical samples with reduced susceptibility to daptomycin and/or resistant to linezolid or glycopeptides
    de la Fuente, Silvia Velasco
    Fernandez-Martinez, Marta
    Lozano, Jesus Rodriguez
    Pablo-Marcos, Daniel
    Siller, Maria
    Montes, Jorge Calvo
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2023, 41 (09): : 567 - 570